HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.

Abstract
The structure of human preproglucagon, as deduced from nucleotide sequencing of the preproglucagon gene, contains two glucagon-like peptides (GLP-1 and GLP-2) in the portion C-terminal to glucagon. A rabbit antiserum was raised against synthetic GLP-1-(1-19) which had 20% cross-reactivity with synthetic GLP-1 and des-Gly37-GLP-1 amide, two possible forms of the GLP-1 whole molecule, but no significant cross-reactivity with glucagon or other pancreatic peptides. Immunocytochemistry revealed that the distribution of GLP-1-(1-19) immunoreactivity followed that of glucagon-like immunoreactivity in the normal human pancreas and in two human glucagon-secreting pancreatic tumors. Chromatography of human pancreas extracts on Sephadex G-50 gave peaks of cross-reactivity at Kav values of 0.06-0.16, 0.34-0.39, 0.54-0.58 (the elution position of synthetic GLP-1), and 0.64-0.70. The concentration of immunoreactivity in the Kav 0.54-0.58 peak measured by RIA using GLP-1 or des-Gly37-GLP-1 amide as standard was 94 +/- 7 pmol/g (mean +/- SEM), while the total pancreatic glucagon content was 4.8 +/- 0.8 nmol/g. One extract of a human glucagon-secreting pancreatic tumor contained a prominent peak of GLP-1-(1-19) peptide cross-reactivity with properties identical to those of GLP-1 or des-Gly37-GLP-1 amide on gel filtration and reverse phase high pressure liquid chromatography, but another tumor contained a preponderance of cross-reactive forms of greater molecular size. Pretreatment plasma from three patients with radiological and biochemical evidence of glucagon-secreting tumors contained a peak of cross-reactivity with the chromatographic properties of intact GLP-1. The low concentrations of intact GLP-1 in normal pancreas compared with pancreatic glucagon concentrations suggest that the majority of the proglucagon is cleaved in a manner that does not produce GLP-1, as defined by its delimiting pairs of basic amino acid residues.
AuthorsL O Uttenthal, M Ghiglione, S K George, A E Bishop, J M Polak, S R Bloom
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 61 Issue 3 Pg. 472-9 (Sep 1985) ISSN: 0021-972X [Print] United States
PMID2991321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucagon-Like Peptide 2
  • Peptide Fragments
  • Peptides
  • Glucagon-Like Peptide 1
Topics
  • Adenoma, Islet Cell (metabolism)
  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide 2
  • Glucagonoma (blood, metabolism)
  • Histocytochemistry
  • Humans
  • Immunoenzyme Techniques
  • Pancreas (metabolism)
  • Pancreatic Neoplasms (blood, metabolism)
  • Peptide Fragments (metabolism)
  • Peptides (blood, metabolism)
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: